LSBWF · LakeShore Biopharma Co., Ltd. · Documents
Market Cap
$2.76M
Shares
41.21M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-06-24 | — | |
| 6-K | 2026-06-22 | — | |
| 6-K | 2026-05-28 | — | |
| 6-K | 2026-04-29 | — | |
| 6-K | 2026-03-25 | — | |
| 6-K | 2026-02-06 | — | |
| 6-K | 2026-01-29 | — | |
| 6-K | 2026-01-20 | — | |
| 6-K | 2025-11-04 | — | |
| 6-K | 2025-09-22 | — | |
| 6-K | 2025-09-12 | — | |
| 6-K | 2025-09-10 | — | |
| 6-K | 2025-08-28 | — | |
| 6-K | 2025-08-18 | — | |
| 20-F | 2025-07-31 | 2025-03-31 | |
| 6-K | 2025-07-31 | — | |
| 6-K | 2025-07-15 | — | |
| 6-K | 2025-07-08 | — | |
| 6-K | 2025-05-12 | — | |
| 6-K | 2025-05-06 | — | |
| 6-K | 2025-03-25 | — | |
| 6-K | 2025-03-12 | — | |
| 6-K | 2024-12-19 | — | |
| 6-K | 2024-12-12 | — | |
| 6-K | 2024-11-12 | — | |
| 6-K | 2024-11-07 | — | |
| 6-K | 2024-11-01 | — | |
| 6-K | 2024-10-29 | — | |
| 6-K | 2024-10-25 | — | |
| 6-K | 2024-10-08 | — | |
| 6-K | 2024-09-27 | — | |
| 6-K/A | 2024-09-10 | — | |
| 6-K | 2024-09-10 | — | |
| 6-K | 2024-09-04 | — | |
| 20-F | 2024-08-15 | 2024-03-31 | |
| 6-K | 2024-08-15 | — | |
| 6-K | 2024-07-05 | — | |
| 6-K | 2024-06-18 | — | |
| 6-K | 2024-06-10 | — | |
| 6-K | 2024-05-24 | — | |
| 6-K | 2024-05-21 | — | |
| 6-K | 2024-05-07 | — | |
| 6-K | 2024-04-29 | — | |
| 6-K | 2024-04-19 | — | |
| 6-K | 2024-04-18 | — | |
| 6-K | 2024-04-09 | — | |
| 6-K | 2024-04-03 | — | |
| 6-K | 2024-03-05 | — | |
| 6-K | 2024-02-23 | — | |
| 6-K | 2024-02-22 | — |
Showing 1–50 of 75 filings